Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience

BACKGROUND: The aim of the study is to evaluate the role of cytoreductive nephrectomy (CN) with thrombectomy before targeted molecular therapy (TMT) on survival in metastatic renal cell carcinoma (mRCC) with venous tumor thrombus. METHODS: We performed a retrospective analysis of 47 patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Nienie, Wu, Pengjie, Chen, Jinchao, Li, Teng, Ning, Xianghui, Wang, Jin, Gong, Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217450/
https://www.ncbi.nlm.nih.gov/pubmed/28056988
http://dx.doi.org/10.1186/s12957-016-1066-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217450/
https://www.ncbi.nlm.nih.gov/pubmed/28056988
http://dx.doi.org/10.1186/s12957-016-1066-3

Ejemplares similares